Armata Pharmaceuticals (ARMP)
Armata Pharmaceuticals on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on NYSE.
900K
Short interest
settlement 2026-10-15
8.5
Days to cover
+2.5 days vs prior
50.9%
Short share of volume
2026-11-02
1,460
Fails to deliver
settlement 2026-10-08
Wed 11 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in ARMP is 899,639 shares, down 63,744 shares over the last month. Over the last 48 readings it ranged from 2,682 shares (29 November 2024) to 964,187 shares (30 September 2026). The latest reading sits at the top of that range. At the reported average volume of 105K shares a day that is 8.5 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/armp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 899,639 | -6.7% | 105,326 | 8.54 |
| 2026-09-30 | 964,187 | +0.1% | 160,890 | 5.99 |
| 2026-09-15 | 963,383 | +8.8% | 583,217 | 1.65 |
| 2026-08-31 | 885,291 | +6.1% | 101,940 | 8.68 |
| 2026-08-14 | 834,737 | -2.5% | 130,045 | 6.42 |
| 2026-07-31 | 856,363 | +21.5% | 171,953 | 4.98 |
| 2026-07-15 | 704,657 | +59.7% | 154,722 | 4.55 |
| 2026-06-30 | 441,157 | +113.3% | 302,873 | 1.46 |
| 2026-06-15 | 206,873 | -1.2% | 53,575 | 3.86 |
| 2026-05-29 | 209,363 | -7.0% | 84,420 | 2.48 |
| 2026-05-15 | 225,033 | -2.2% | 77,207 | 2.91 |
| 2026-04-30 | 230,017 | -5.8% | 79,680 | 2.89 |
| 2026-04-15 | 244,306 | -18.0% | 55,070 | 4.44 |
| 2026-03-31 | 297,898 | -4.2% | 30,843 | 9.66 |
| 2026-03-13 | 310,810 | +4.3% | 33,179 | 9.37 |
| 2026-02-27 | 298,102 | -0.1% | 66,765 | 4.46 |
| 2026-02-13 | 298,337 | +8.5% | 44,863 | 6.65 |
| 2026-01-30 | 274,891 | +23.8% | 41,454 | 6.63 |
| 2026-01-15 | 222,054 | +53.8% | 75,408 | 2.94 |
| 2025-12-31 | 144,352 | +7.7% | 27,287 | 5.29 |
| 2025-12-15 | 133,987 | +2.1% | 58,701 | 2.28 |
| 2025-11-28 | 131,252 | -16.5% | 69,711 | 1.88 |
| 2025-11-14 | 157,247 | +410.1% | 131,974 | 1.19 |
| 2025-10-31 | 30,828 | +40.3% | 1,242,999 | 1.00 |
| 2025-10-15 | 21,970 | -8.3% | 10,537 | 2.09 |
| 2025-09-30 | 23,958 | -14.2% | 8,433 | 2.84 |
| 2025-09-15 | 27,906 | -24.1% | 14,859 | 1.88 |
| 2025-08-29 | 36,748 | -25.8% | 9,704 | 3.79 |
| 2025-08-15 | 49,502 | -1.9% | 8,376 | 5.91 |
| 2025-07-31 | 50,466 | -24.9% | 12,417 | 4.06 |
| 2025-07-15 | 67,235 | -35.1% | 16,992 | 3.96 |
| 2025-06-30 | 103,565 | -22.8% | 22,013 | 4.70 |
| 2025-06-13 | 134,133 | -25.0% | 21,100 | 6.36 |
| 2025-05-30 | 178,806 | +4178.7% | 1,451,829 | 1.00 |
| 2025-05-15 | 4,179 | -44.5% | 12,128 | 1.00 |
| 2025-04-30 | 7,525 | +20.5% | 9,172 | 1.00 |
| 2025-04-15 | 6,245 | +71.9% | 33,480 | 1.00 |
| 2025-03-31 | 3,633 | -52.8% | 23,389 | 1.00 |
| 2025-03-14 | 7,691 | +27.3% | 9,431 | 1.00 |
| 2025-02-28 | 6,043 | -14.3% | 13,476 | 1.00 |
| 2025-02-14 | 7,052 | -62.1% | 7,188 | 1.00 |
| 2025-01-31 | 18,609 | +7.9% | 8,345 | 2.23 |
| 2025-01-15 | 17,251 | -6.6% | 12,872 | 1.34 |
| 2024-12-31 | 18,477 | +204.8% | 18,453 | 1.00 |
| 2024-12-13 | 6,062 | +126.0% | 6,595 | 1.00 |
| 2024-11-29 | 2,682 | -66.3% | 11,581 | 1.00 |
| 2024-11-15 | 7,950 | +75.1% | 11,220 | 1.00 |
| 2024-10-31 | 4,540 | -23.5% | 5,583 | 1.00 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of ARMP volume is 50.9%, down 2.3 points over the last five sessions. Over the last 30 readings it ranged from 29.4% (22 September 2026) to 88.8% (22 October 2026). The latest reading is 15.9 points below the 30-session average of 66.8%, on 40K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 21K | 40K | 50.9% | 1,248 |
| 2026-10-30 | 7K | 10K | 74.5% | 0 |
| 2026-10-29 | 31K | 48K | 64.3% | 0 |
| 2026-10-28 | 19K | 31K | 61.4% | 0 |
| 2026-10-27 | 25K | 35K | 71.0% | 0 |
| 2026-10-26 | 14K | 26K | 53.1% | 0 |
| 2026-10-23 | 23K | 31K | 71.6% | 0 |
| 2026-10-22 | 39K | 44K | 88.8% | 0 |
| 2026-10-21 | 37K | 46K | 80.7% | 0 |
| 2026-10-20 | 25K | 32K | 80.4% | 0 |
| 2026-10-19 | 44K | 52K | 83.8% | 0 |
| 2026-10-16 | 22K | 56K | 39.9% | 0 |
| 2026-10-15 | 53K | 61K | 87.1% | 7,634 |
| 2026-10-14 | 39K | 50K | 78.3% | 9,194 |
| 2026-10-13 | 46K | 86K | 53.2% | 8,813 |
| 2026-10-12 | 13K | 22K | 60.0% | 0 |
| 2026-10-09 | 26K | 34K | 78.5% | 0 |
| 2026-10-08 | 18K | 30K | 59.2% | 0 |
| 2026-10-07 | 27K | 31K | 85.5% | 0 |
| 2026-10-06 | 41K | 50K | 82.1% | 0 |
| 2026-10-05 | 14K | 18K | 80.6% | 0 |
| 2026-10-02 | 31K | 44K | 69.1% | 1,573 |
| 2026-10-01 | 15K | 19K | 77.5% | 0 |
| 2026-09-30 | 15K | 42K | 36.2% | 0 |
| 2026-09-29 | 21K | 45K | 46.8% | 0 |
| 2026-09-28 | 21K | 29K | 71.3% | 0 |
| 2026-09-25 | 14K | 37K | 38.9% | 16 |
| 2026-09-24 | 47K | 64K | 73.2% | 3,260 |
| 2026-09-23 | 95K | 124K | 76.7% | 20,211 |
| 2026-09-22 | 14K | 48K | 29.4% | 0 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 October 2026, the fails-to-deliver balance in ARMP is 1,460 shares, down 2,856 shares over the last settlement date. Over the last 30 readings it ranged from 3 shares (24 July 2026) to 10,367 shares (24 June 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-08 | 1,460 | $3.81 | $6K |
| 2026-10-02 | 4,316 | $3.31 | $14K |
| 2026-10-01 | 2,905 | $3.67 | $11K |
| 2026-09-30 | 2,318 | $3.59 | $8K |
| 2026-09-28 | 508 | $3.74 | $2K |
| 2026-09-24 | 2,194 | $3.64 | $8K |
| 2026-09-18 | 250 | $4.10 | $1K |
| 2026-09-17 | 250 | $4.07 | $1K |
| 2026-09-16 | 5,098 | $4.40 | $22K |
| 2026-09-15 | 4,815 | $5.55 | $27K |
| 2026-09-14 | 418 | $5.38 | $2K |
| 2026-09-11 | 900 | $5.23 | $5K |
| 2026-09-10 | 981 | $5.41 | $5K |
| 2026-09-04 | 2,116 | $5.52 | $12K |
| 2026-08-28 | 9 | $5.43 | $49 |
| 2026-08-27 | 1,426 | $5.45 | $8K |
| 2026-08-24 | 2,394 | $5.10 | $12K |
| 2026-08-20 | 4,159 | $5.07 | $21K |
| 2026-08-04 | 899 | $5.05 | $5K |
| 2026-07-28 | 671 | $5.15 | $3K |
| 2026-07-24 | 3 | $5.22 | $16 |
| 2026-07-23 | 1,772 | $5.24 | $9K |
| 2026-07-22 | 483 | $5.16 | $2K |
| 2026-07-20 | 92 | $4.51 | $415 |
| 2026-07-17 | 2,294 | $3.76 | $9K |
| 2026-07-02 | 1,239 | $5.88 | $7K |
| 2026-06-26 | 7 | $6.50 | $46 |
| 2026-06-24 | 10,367 | $7.01 | $73K |
| 2026-06-22 | 308 | $7.08 | $2K |
| 2026-06-15 | 3,950 | $7.58 | $30K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for ARMP in the last 90 days. The most recent filings are listed below. Latest filing: Birx Deborah (Chief Executive Officer) on 2026-07-10.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Birx Deborah | Chief Executive Officer | Tax withholding | 14K | $4.26 | $60K | 198K |
| 2026-03-14 | Kyme Pierre | Chief Business Officer | Tax withholding | 1K | $10.54 | $11K | 9K |
| 2026-03-14 | Birx Deborah | Chief Executive Officer | Tax withholding | 5K | $10.54 | $52K | 212K |
| 2025-07-10 | Birx Deborah | Chief Executive Officer | Tax withholding | 14K | $2.27 | $31K | 217K |
| 2025-03-14 | Kyme Pierre | Chief Business Officer | Tax withholding | 1K | $1.95 | $2K | 10K |
| 2025-03-14 | Birx Deborah | Chief Executive Officer | Tax withholding | 6K | $1.95 | $12K | 231K |
| 2024-07-10 | Birx Deborah | Chief Executive Officer | Tax withholding | 23K | $2.68 | $61K | 237K |
| 2024-03-14 | Birx Deborah | Chief Executive Officer | Grant | 60K | $0.00 | $0 | 260K |
| 2024-03-14 | Rychlik Richard | Corporate Controller and PFO | Grant | 10K | $0.00 | $0 | 10K |
| 2023-12-21 | Birx Deborah | Chief Executive Officer | Grant | 200K | $0.00 | $0 | 200K |
| 2022-03-31 | Innoviva, Inc. | Director,TenPercentOwner | Buy | 5.4M | $5.00 | $26.9M | 16.4M |
| 2022-02-09 | Innoviva Strategic Opportunities LLC | Director,TenPercentOwner | Buy | 3.6M | $5.00 | $18.1M | 11.0M |
| 2021-10-29 | Innoviva Strategic Opportunities LLC | Director,TenPercentOwner | Buy | 1.2M | $3.30 | $4.0M | 7.4M |
| 2021-03-17 | Innoviva, Inc. | Director,TenPercentOwner | Buy | 4.3M | $3.25 | $13.9M | 6.2M |
| 2021-01-26 | Innoviva Strategic Opportunities LLC | Director,TenPercentOwner | Buy | 1.9M | $3.25 | $6.1M | 1.9M |
| 2020-03-27 | Innoviva, Inc. | TenPercentOwner | Buy | 7.7M | $2.87 | $22.1M | 8.7M |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON2 holders report 5% or more of ARMP in their latest filing, all on Schedule 13D (active intent). The largest reported stake is Innoviva, Inc. at 82.7% of the class (55,467,459 shares), filed 2026-05-13 for an event on 2026-05-12.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-13 | 13D/Ano. 15 | Innoviva, Inc.corporation | 55.5M | 82.7% | 2026-05-12 |
| 2026-05-13 | 13D/Ano. 15 | Innoviva Strategic Opportunities LLCother entity | 46.8M | 69.7% | 2026-05-12 |
13F holders
Tracked managers holding ARMP at their latest 13F. JSON2 of the 30 tracked managers held ARMP at their latest 13F, $3.4M in total at quarter-end prices. Millennium Management is the largest at $3.0M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 471K | $3.0M | 0.00% | +213K |
| Renaissance Technologies | 2026-06-30 | 48K | $313K | 0.00% | +10K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Armata Pharmaceuticals in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Armata Pharmaceuticals (ARMP), SEC CIK 921114, listed on NYSE. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-05-13.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-12.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-07-10.JSON and CSV
- Company record
- EDGAR filing index for CIK 921114Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other company pages
- STESTERIS
- STLDSteel Dynamics
- STRCStrategy
- STRLSterling Infrastructure
- STTState Street
- STXSeagate Technology Holdings
- STZConstellation Brands
- SUISun Communities
- SUNBSunbelt Rentals Holdings
- SWSmurfit Westrock
- SWKStanley Black & Decker
- SWKSSkyworks Solutions
- SXTCChina SXT Pharmaceuticals
- SYFSynchrony Financial
- SYKStryker
- SYNASynaptics
- SYRESpyre Therapeutics
- SYYSysco
- TAT&T
- TAPMolson Coors
- TCOMTrip.com Group
- TDToronto-Dominion Bank
- TDGTransDigm Group
- TDYTeledyne Technologies
Datasets
Frequently Asked Questions
How much of ARMP is sold short?
What is ARMP's daily short volume?
Does ARMP have fails to deliver?
Are ARMP insiders buying or selling?
Who owns 5% or more of ARMP?
Which tracked 13F managers own ARMP?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.